49 phenotypes from 8 alleles in 13 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Tg(Krt19-Wnt1)2Maos/0 involves: C3H * C57BL/6	abnormal stomach glandular epithelium morphology	J:116782
	abnormal stomach glandular region morphology	J:116782
Tg(Wnt1)1Hev/0 either: FVB/N or (involves: C57BL/6 * SJL)	abnormal branching of the mammary ductal tree	J:28473
	abnormal mammary gland lobule morphology	J:28473
	abnormal mammary gland morphology	J:28473
	mammary gland alveolar hyperplasia	J:28473
Tg(Wnt1)1Hev/0 involves: 129P2/OlaHsd * C57BL/6 * SJL	increased mammary adenocarcinoma incidence	J:54215
	mammary gland alveolar hyperplasia	J:54215
	mammary gland duct hyperplasia	J:54215
	mammary gland hyperplasia	J:54215
Tg(Wnt1)1Hev/0 involves: C57BL/6 * FVB * SJL	abnormal branching of the mammary ductal tree	J:96305
	increased mammary gland tumor incidence	J:96305
	mammary gland hyperplasia	J:96305
Tg(Wnt1)1Hev/0 involves: C57BL/6 * SJL	increased mammary adenocarcinoma incidence	J:61009
	mammary gland duct hyperplasia	J:61009
Wnt1sw/Wnt1sw B6C3Fe a/a-Wnt1sw/J	reduced linear vestibular evoked potential	J:116914
Wnt1sw/Wnt1sw involves: B6C3Fe * C57BL/6J	absent midbrain-hindbrain boundary	J:29060
Wnt1sw/Wnt1sw Not Specified	abnormal brain white matter morphology	J:30722
	abnormal cerebellar cortex morphology	J:30722
	abnormal cerebellum anterior vermis morphology	J:30722
	abnormal cerebellum development	J:1970, J:30722
	abnormal gait	J:15063
	abnormal inferior colliculus morphology	J:30722
	abnormal locomotor coordination	J:15063
	abnormal posture	J:15063
	ataxia	J:30722
	impaired swimming	J:15063
	muscle hypertonia	J:30722
	weaving	J:15063
Wnt1tm1.1Mze/Wnt1tm1.1Mze En1tm2(cre)Wrst/En1+ involves: 129S1/Sv * 129X1/SvJ * C57BL/6N	abnormal midbrain morphology	J:194842
	decreased midbrain size	J:194842
	decreased rhombomere 1 size	J:194842
Wnt1tm1Amc/Wnt1tm1Amc involves: 129S1/Sv * C57BL/6J	abnormal hindbrain development	J:118582
	absent metencephalon	J:118582
	absent midbrain	J:118582
	prenatal lethality, complete penetrance	J:118582
Wnt1tm1b(EUCOMM)Wtsi/Wnt1+ C57BL/6N-Wnt1tm1b(EUCOMM)Wtsi/Tcp	increased circulating cholesterol level	J:211773
	increased circulating creatinine level	J:211773
Wnt1tm1b(EUCOMM)Wtsi/Wnt1tm1b(EUCOMM)Wtsi C57BL/6N-Wnt1tm1b(EUCOMM)Wtsi/Tcp	preweaning lethality, complete penetrance	J:211773
	preweaning lethality, incomplete penetrance	J:211773
Wnt1tm1Brd/Wnt1tm1Brd involves: 129S7/SvEvBrd * C57BL/6J	abnormal cranial flexure morphology	J:10730
	abnormal forebrain morphology	J:10730
	abnormal metencephalon morphology	J:10730
	abnormal midbrain development	J:10730
	abnormal midbrain-hindbrain boundary development	J:10730
	abnormal parietal bone morphology	J:44094
	absent cerebellum	J:10730
	absent midbrain	J:10730
	decreased rhombomere 1 size	J:10730
	decreased thymocyte number	J:75999
	neonatal lethality, complete penetrance	J:10730
Wnt1tm1Mrc/Wnt1tm1Mrc involves: 129S7/SvEvBrd * C57BL/6	abnormal frontal lobe morphology	J:67737
	abnormal metencephalon morphology	J:67737
	abnormal midbrain morphology	J:67737
	abnormal motor coordination/balance	J:67737
	absent cerebellum	J:67737
	ataxia	J:67737
	hydrocephaly	J:67737
	lethality throughout fetal growth and development, incomplete penetrance	J:67737
	neonatal lethality, incomplete penetrance	J:67737